Fierce Pharma
JUNE 21, 2024
In this week’s episode of “The Top Line,” Fierce Pharma’s Zoey Becker sits down with Bobby Sheng, the CEO of Bora Pharmaceuticals, to discuss the concept of “friend-shoring” in drug manufacturing.< | In this week’s episode of “The Top Line,” Fierce Pharma’s Zoey Becker sits down with Bobby Sheng, the CEO of Bora Pharmaceuticals, to discuss the concept of “friend-shoring” in drug manufacturing.
MedCity News
JUNE 21, 2024
FDA reviewers concluded the data for Sarepta Therapeutics’ Elevidys were insufficient to show efficacy in the rare muscle disorder Duchenne muscular dystrophy. Peter Marks, the agency’s top biologics official, reviewed the same data and reached a different conclusion. The post FDA Approves Sarepta Gene Therapy, But Only After Top FDA Official Bucks Agency Staff appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JUNE 21, 2024
Amid an influx of efforts to help the African continent claim vaccine sovereignty, a new financing mechanism devised by Gavi, the Vaccine Alliance, the African Union and the Africa Centres for Dise | Amid an influx of efforts to help the African continent claim vaccine sovereignty, a new financing mechanism devised by Gavi, the Vaccine Alliance, the African Union and the Africa Centres for Disease Control and Prevention (Africa CDC) has taken flight.
MedCity News
JUNE 21, 2024
This not only enhances the quality of care and patient satisfaction but also optimizes operational efficiency. The post AI-Driven Breakthroughs: Transforming Patient Care through Research Consulting appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
JUNE 21, 2024
For more than a decade, argenx has sought to apply its novel antibody fragment treat | Argenx's Vyvgart has won approval to treat its second indication in the U.S. and its third globally after the U.S. FDA cleared the med to treat the rare and debilitating peripheral nervous system disease chronic inflammatory demyelinating polyneuropathy (CIDP).
MedCity News
JUNE 21, 2024
Underrepresentation of racial and ethnic groups and other historically disenfranchised populations in clinical trials continues to be a major challenge. Medical Affairs can help identify solutions. The post The Role of Medical Affairs in Bridging Clinical Trial Access for All Patients appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JUNE 21, 2024
MedCity’s annual INVEST Digital Health conference in Dallas September 18 will delve into innovation at the intersection of AI and drug development, investment trends, consumer-focused diagnostics and validating digital health tools. The post What’s on the Agenda for MedCity INVEST Digital Health in Dallas? appeared first on MedCity News.
European Pharmaceutical Review
JUNE 21, 2024
Gilead Sciences ’ twice-yearly injectable HIV-1 capsid inhibitor enabled 100 percent efficacy for investigational use of HIV prevention in cisgender women. This is according to interim analysis topline results of the Phase III PURPOSE 1 trial. Lenacapavir showed superiority to once-daily oral Truvada ® (emtricitabine 200mg and tenofovir disoproxil fumarate 300mg; F/TDF) and background HIV incidence (bHIV).
pharmaphorum
JUNE 21, 2024
Sustainability is all important for the planet and its people, and in today’s podcast web editor Nicole Raleigh speaks with Harriet Lewis, director of public affairs and communications at Chiesi UK & Ireland, about how partnerships between the NHS and pharma industry can support the journey to more sustainable practices, from R&D and drug reimbursement to medicines and recycling.
MedCity News
JUNE 21, 2024
Knownwell acquired one of its competitors, just six months after announcing its $20 million Series A funding round. The startup, which provides hybrid primary care and metabolic health treatment, bought Alfie Health, an online obesity management clinic with an AI platform that generates personalized recommendations for weight management. The post Knownwell Acquires Competitor to Expand Access to Comprehensive Obesity Care appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
JUNE 21, 2024
Trial investigators anticipate that the FDA will decide on approval for linvoseltamab in relapsed/refractory multiple myeloma by the end of 2024.
Pharmaceutical Commerce
JUNE 21, 2024
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
pharmaphorum
JUNE 21, 2024
Twice-yearly lenacapavir injection provides 100% protection from HIV when used as PrEP in cisgender women, says Gilead.
Pharmaceutical Technology
JUNE 21, 2024
Both Novo Nordisk and Eli Lilly have filed lawsuits against unapproved sellers of their diabetes and weight loss drugs.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Clarivate
JUNE 21, 2024
AI and systematic literature reviews: potential benefits and use cases Good quality evidence is the hallmark of any successful roadmap to access. Systematic literature reviews (SLRs) and meta-analysis are generally considered to be among the most robust forms of evidence; their adherence to strict methodological guidelines helps negate the inherent bias of researchers.
pharmaphorum
JUNE 21, 2024
NWEH launches software that takes legwork out of serious adverse event reporting in clinical trials and could reduce costs.
PharmaTimes
JUNE 21, 2024
The method provides a more accurate and ethical approach to drug testing for medicines
pharmaphorum
JUNE 21, 2024
Chimps’ self-medication with plants could aid drug discovery Phil.
MedCity News
JUNE 21, 2024
In a recent interview, Don Antonucci, president and CEO of Providence Health Plan, spoke about how the industry needs to improve value-based care. The post What’s Missing from Value-Based Care Convos, According to Providence Health Plan’s CEO appeared first on MedCity News.
PharmaTimes
JUNE 21, 2024
According to WHO, cardiovascular diseases are responsible for 17.
Clear Pivot
JUNE 21, 2024
An organization that’s not looking for ways to get ahead is already falling behind. Maturing tech has given rise to a new approach to getting ahead that you might (or might not) know as Revenue Operations (RevOps). It’s critical to making every part of a business work together better, so successful growth depends on it. But being a newly-emerging field, RevOps is still in the process of being defined.
Scott Burrows
JUNE 21, 2024
In a world filled with stories of resilience and triumph, my journey stands as a testament to the power of determination and unwavering optimism. From the heights of athletic glory to the depths of life-altering challenges, I have navigated a path guided by three fundamental principles: vision, mindset, and grit. Embracing Vision: Seeing Beyond Circumstances My story began on the football field, where I excelled as a star wide receiver for Florida State University.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmaTech
JUNE 21, 2024
President and CEO of Pharmaceutics International, Inc. (Pii), John Fowler, reacts to the agility and flexibility needed to support the development and manufacture of today's complex biotherapeutics.
Pharmaceutical Technology
JUNE 21, 2024
South Korea is moving forward with reforming its national health insurance system to improve patients' access to healthcare support under the Second Stage Comprehensive Insurance Plan, for the period 2024-28.
PharmExec
JUNE 21, 2024
Results of the PURPOSE 1 trial indicated that a twice-yearly injection of lenacapavir outperformed the once-daily oral Truvada preventing HIV in cisgender women.
Pharmaceutical Technology
JUNE 21, 2024
The company has also raised $130.7m in a private placement, which along with Tectonics' previous cash reserves.
PharmExec
JUNE 21, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
JUNE 21, 2024
AstraZeneca has received approval for Truqap in combination with Faslodex in the EU to treat certain advanced breast cancer cases in adults.
PharmExec
JUNE 21, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Commerce
JUNE 21, 2024
Mark Bouck discusses PharmAlliance’s latest acquisitions, while reiterating its goals surrounding health economics and outcomes research.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
271 
Let's personalize your content